Dr. Daniel L. Kapp, MD

Dr. Kapp practices at Palm Beach Plastic Surgery Center in West Palm Beach, Florida.

Dr. Kapp's NPI, 1235132416, was assigned on May 23, 2005. Dr. Kapp graduated from USF Health Morsani College of Medicine in 1998. Dr. Kapp holds Florida license ME90122.

Dr. Kapp's primary practice is Palm Beach Plastic Surgery Center, at 1500 N Dixie Hwy, West Palm Beach, FL 33401 in Palm Beach County. The practice phone is (561) 833-4022.

Dr. Kapp's primary practice is Palm Beach Plastic Surgery Center in West Palm Beach, Florida. Dr. Kapp is also affiliated with Good Samaritan Medical Center. The medical group on file is Daniel L. Kapp, MD. Dmand AI also links Dr. Kapp to 2 more group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kapp practices, 4 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Kapp's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Kapp is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Kapp's licenses on file in 3 states: Florida, Ohio and Massachusetts.

Dmand AI lists breast reconstruction, cancerous skin growth removal, head wound, lymphedema and minor head injury among the conditions Dr. Kapp treats.

CMS data shows 1,421 Medicare services from Dr. Kapp across 14 procedure codes in 2024, for 313 Medicare patients. Medicare paid $402,155 for them. Every service was in an office.

CMS counts 313 Medicare patients who saw Dr. Kapp in 2024. The largest group is 75 to 84, with 126 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kapp's median patient age at 72, with 65% women.

In 2024, Dr. Kapp wrote 240 Medicare Part D claims for 111 patients. 91% of them were for generic drugs. CMS names the drug for 206 of them, across 9 drugs with 11 or more claims each, at $7,960 in total drug cost. In 2023, CMS named 98 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kapp for performance year 2024, reported individually. Dr. Kapp accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 163 procedures of removal of tissue by Dr. Kapp, more than 90% of the clinicians it reports for that procedure.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Kapp in 2018. The most frequent topics are Wound Healing, Skin Neoplasms and Debridement. Dr. Kapp has published most often in J Wound Care. Dr. Kapp's most frequent co-authors are Michael W. Chen, MD, Jonathan L. Cook, MD and Irfan Galaria, MBA, MD.

CMS Open Payments shows 843 general payments to Dr. Kapp from 46 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. Organogenesis Inc. paid the most, $380,807.

Dr. Kapp graduated from USF Health Morsani College of Medicine in 1998. Dr. Kapp is a member of ASPS.

Dr. Kapp is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.